Teladoc Health Reports First Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
Teladoc (TDOC) Q1 Revenue Misses Consensus, Offers Guidance
April 27, 2022 4:10 PM EDTTeladoc (NYSE: TDOC) reported Q1 EPS of ($41.58), may not compare to the analyst estimate of ($0.56). Revenue for the quarter came in at $565.4 million versus the consensus estimate of $568.8 million.
Net loss per share of $41.58, primarily driven by non-cash goodwill impairment charge of $6.6... More